Lv61
2140 积分 2022-04-29 加入
Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough
1个月前
已完结
APSR 2024 Abstracts
1个月前
已完结
The Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on the Pharmacokinetics and Safety of Camlipixant in Healthy Participants
1个月前
已完结
The Impact of Itraconazole, a Strong CYP3A4 Inhibitor, on the Pharmacokinetics and Safety of Camlipixant in Healthy Participants
1个月前
已完结
Effect of Camlipixant on Cardiac Repolarization in Healthy Participants: A Thorough QT/QTc Study
1个月前
已完结
Randomized, controlled, proof-of-concept trial of gefapixant for endometriosis-related pain
1个月前
已完结
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial
1个月前
已完结
Red Blood Cells: A Neglected Compartment in Pharmacokinetics and Pharmacodynamics
2个月前
已完结
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials
2个月前
已完结
LPA Receptors: Subtypes and Biological Actions
2个月前
已完结
皖公网安备34019202002308
